Background Although many studies have found an association betweenHelicobacter pylori infection and the development of gastriccancer, many aspects of this relation remain uncertain.
Methods We prospectively studied 1526 Japanese patients whohad duodenal ulcers, gastric ulcers, gastric hyperplasia, ornonulcer dyspepsia at the time of enrollment; 1246 had H. pyloriinfection and 280 did not. The mean follow-up was 7.8 years(range, 1.0 to 10.6). Patients underwent endoscopy with biopsyat enrollment and then between one and three years after enrollment.H. pylori infection was assessed by histologic examination,serologic testing, and rapid urease tests and was defined bya positive result on any of these tests.
Results Gastric cancers developed in 36 (2.9 percent) of theinfected and none of the uninfected patients. There were 23intestinal-type and 13 diffuse-type cancers. Among the patientswith H. pylori infection, those with severe gastric atrophy,corpus-predominant gastritis, and intestinal metaplasia wereat significantly higher risk for gastric cancer. We detectedgastric cancers in 21 (4.7 percent) of the 445 patients withnonulcer dyspepsia, 10 (3.4 percent) of the 297 with gastriculcers, 5 (2.2 percent) of the 229 with gastric hyperplasticpolyps, and none of the 275 with duodenal ulcers.
Conclusions Gastric cancer develops in persons infected withH. pylori but not in uninfected persons. Those with histologicfindings of severe gastric atrophy, corpus-predominant gastritis,or intestinal metaplasia are at increased risk. Persons withH. pylori infection and nonulcer dyspepsia, gastric ulcers,or gastric hyperplastic polyps are also at risk, but those withduodenal ulcers are not.
Source Information
From the Departments of Gastroenterology (N.U., S.O., S.Y., N.M., S.Y., M.Y.) and Clinical Pathology (K.T., N.S.), Kure Kyosai Hospital, Kure City; and the Department of Internal Medicine, Fukuoka University School of Medicine, Fukuoka (R.J.S.) both in Japan.
Address reprint requests to Dr. Uemura at the Department of Gastroenterology, Kure Kyosai Hospital, 2-3-28 Nishi-chuo, Kure City, Japan, or at n-uemura{at}mua.biglobe.ne.jp.
Peek, R. M. Jr
(2008). Review: Prevention of gastric cancer: When is treatment of Helicobacter pylori warranted?. Therapeutic Advances in Gastroenterology
1: 19-31
[Abstract]
Shibata, W., Maeda, S., Hikiba, Y., Yanai, A., Sakamoto, K., Nakagawa, H., Ogura, K., Karin, M., Omata, M.
(2008). c-Jun NH2-Terminal Kinase 1 Is a Critical Regulator for the Development of Gastric Cancer in Mice. Cancer Res.
68: 5031-5039
[Abstract][Full Text]
Prasad, K. N., Saxena, A., Ghoshal, U. C., Bhagat, M. R., Krishnani, N.
(2008). Analysis of Pro12Ala PPAR gamma polymorphism and Helicobacter pylori infection in gastric adenocarcinoma and peptic ulcer disease. Ann Oncol
19: 1299-1303
[Abstract][Full Text]
Takaishi, S., Okumura, T., Wang, T. C.
(2008). Gastric Cancer Stem Cells. JCO
26: 2876-2882
[Abstract][Full Text]
Chochi, K., Ichikura, T., Kinoshita, M., Majima, T., Shinomiya, N., Tsujimoto, H., Kawabata, T., Sugasawa, H., Ono, S., Seki, S., Mochizuki, H.
(2008). Helicobacter pylori Augments Growth of Gastric Cancers via the Lipopolysaccharide-Toll-like Receptor 4 Pathway whereas Its Lipopolysaccharide Attenuates Antitumor Activities of Human Mononuclear Cells. Clin. Cancer Res.
14: 2909-2917
[Abstract][Full Text]
Kiltz, U., Zochling, J., Schmidt, W. E., Braun, J.
(2008). Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?. Rheumatology (Oxford)
0: ken123v1-ken123
[Abstract][Full Text]
Douraghi, M., Mohammadi, M., Oghalaie, A., Abdirad, A., Mohagheghi, M. A., Hosseini, M. E., Zeraati, H., Ghasemi, A., Esmaieli, M., Mohajerani, N.
(2008). dupA as a risk determinant in Helicobacter pylori infection. J Med Microbiol
57: 554-562
[Abstract][Full Text]
Rugge, M., Kim, J. G., Mahachai, V., Miehlke, S., Pennelli, G., Russo, V. M., Perng, C.-L., Chang, F.-Y., Tandon, R. K., Singal, D. K., Sung, J. J.Y., Valenzuela, J. E., Realdi, G., Dore, M. P., Graham, D. Y
(2008). OLGA Gastritis Staging in Young Adults and Country-Specific Gastric Cancer Risk. INT J SURG PATHOL
16: 150-154
[Abstract]
Ryan, K. A., Daly, P., Li, Y., Hooton, C., O'Toole, P. W.
(2008). Strain-specific inhibition of Helicobacter pylori by Lactobacillus salivarius and other lactobacilli. J Antimicrob Chemother
61: 831-834
[Abstract][Full Text]
Mita, M., Satoh, M., Shimada, A., Okajima, M., Azuma, S., Suzuki, J. S., Sakabe, K., Hara, S., Himeno, S.
(2008). Metallothionein is a crucial protective factor against Helicobacter pylori-induced gastric erosive lesions in a mouse model. Am. J. Physiol. Gastrointest. Liver Physiol.
294: G877-G884
[Abstract][Full Text]
Tiwari, S K, Manoj, G, Kumar, G V., Sivaram, G, Hassan, S I, Prabhakar, B, Devi, U, Jalaluddin, S, Kumar, K, Ahmed, S, Abid, Z, Habeeb, M A, Khan, A A, Habibullah, C M
(2008). Prognostic significance of genotyping Helicobacter pylori infection in patients in younger age groups with gastric cancer. Postgrad. Med. J.
84: 193-197
[Abstract][Full Text]
Lochhead, P., El-Omar, E. M.
(2008). Gastric cancer. Br Med Bull
85: 87-100
[Abstract][Full Text]
Derakhshan, M H, Malekzadeh, R, Watabe, H, Yazdanbod, A, Fyfe, V, Kazemi, A, Rakhshani, N, Didevar, R, Sotoudeh, M, Zolfeghari, A A, McColl, K E L
(2008). Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut
57: 298-305
[Abstract][Full Text]
Con, S. A., Con-Wong, R., Con-Chin, G. R., Con-Chin, V. G., Takeuchi, H., Valerin, A. L., Echandi, G., Mena, F., Brenes, F., Yasuda, N., Araki, K., Sugiura, T.
(2007). Serum Pepsinogen Levels, Helicobacter pylori CagA Status, and Cytokine Gene Polymorphisms Associated with Gastric Premalignant Lesions in Costa Rica. Cancer Epidemiol. Biomarkers Prev.
16: 2631-2636
[Abstract][Full Text]
de Vries, A C, Meijer, G A, Looman, C W N, Casparie, M K, Hansen, B E, van Grieken, N C T, Kuipers, E J
(2007). Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut
56: 1665-1670
[Abstract][Full Text]
Liu, Y.-T., Shang, D., Akatsuka, S., Ohara, H., Dutta, K. K., Mizushima, K., Naito, Y., Yoshikawa, T., Izumiya, M., Abe, K., Nakagama, H., Noguchi, N., Toyokuni, S.
(2007). Chronic Oxidative Stress Causes Amplification and Overexpression of ptprz1 Protein Tyrosine Phosphatase to Activate -Catenin Pathway. Am. J. Pathol.
171: 1978-1988
[Abstract][Full Text]
Tsukamoto, T., Mizoshita, T., Tatematsu, M.
(2007). Invited Review: Animal Models of Stomach Carcinogenesis. Toxicol Pathol
35: 636-648
[Abstract]
Watari, J, Tanaka, A, Tanabe, H, Sato, R, Moriichi, K, Zaky, A, Okamoto, K, Maemoto, A, Fujiya, M, Ashida, T, Das, K M, Kohgo, Y
(2007). K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer. J. Clin. Pathol.
60: 921-926
[Abstract][Full Text]
Hansen, S., Vollset, S. E., Derakhshan, M. H, Fyfe, V., Melby, K. K, Aase, S., Jellum, E., McColl, K. E L
(2007). Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut
56: 918-925
[Abstract][Full Text]
Egi, Y., Ito, M., Tanaka, S., Imagawa, S., Takata, S., Yoshihara, M., Haruma, K., Chayama, K.
(2007). Role of Helicobacter pylori Infection and Chronic Inflammation in Gastric Cancer in the Cardia. Jpn J Clin Oncol
0: hym029v1-6
[Abstract][Full Text]
Suzuki, G., Cullings, H., Fujiwara, S., Hattori, N., Matsuura, S., Hakoda, M., Akahoshi, M., Kodama, K., Tahara, E.
(2007). Low-Positive Antibody Titer against Helicobacter pylori Cytotoxin-Associated Gene A (CagA) May Predict Future Gastric Cancer Better Than Simple Seropositivity against H. pylori CagA or against H. pylori. Cancer Epidemiol. Biomarkers Prev.
16: 1224-1228
[Abstract][Full Text]
Miki, K., Urita, Y., Ishikawa, F., Iino, T., Shibahara-Sone, H., Akahoshi, R., Mizusawa, S., Nose, A., Nozaki, D., Hirano, K., Nonaka, C., Yokokura, T.
(2007). Effect of Bifidobacterium bifidum Fermented Milk on Helicobacter pylori and Serum Pepsinogen Levels in Humans. J DAIRY SCI
90: 2630-2640
[Abstract][Full Text]
Malfertheiner, P, Megraud, F, O'Morain, C, Bazzoli, F, El-Omar, E, Graham, D, Hunt, R, Rokkas, T, Vakil, N, Kuipers, E J, The European Helicobacter Study Group (EHSG),
(2007). Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut
56: 772-781
[Abstract][Full Text]
Lin, Y.-F., Chen, C.-Y., Tsai, M.-H., Wu, M.-S., Wang, Y.-C., Chuang, E. Y., Lin, J.-T., Yang, P.-C., Chow, L.-P.
(2007). Duodenal Ulcer-related Antigens from Helicobacter pylori: Immunoproteome and Protein Microarray Approaches. Mol. Cell. Proteomics
6: 1018-1026
[Abstract][Full Text]
Nagai, S., Mimuro, H., Yamada, T., Baba, Y., Moro, K., Nochi, T., Kiyono, H., Suzuki, T., Sasakawa, C., Koyasu, S.
(2007). Role of Peyer's patches in the induction of Helicobacter pylori-induced gastritis. Proc. Natl. Acad. Sci. USA
104: 8971-8976
[Abstract][Full Text]
Rugge, M., Meggio, A., Pennelli, G., Piscioli, F., Giacomelli, L., De Pretis, G., Graham, D. Y
(2007). Gastritis staging in clinical practice: the OLGA staging system. Gut
56: 631-636
[Abstract][Full Text]
Ferreccio, C., Rollan, A., Harris, P. R., Serrano, C., Gederlini, A., Margozzini, P., Gonzalez, C., Aguilera, X., Venegas, A., Jara, A.
(2007). Gastric Cancer is Related to Early Helicobacter pylori Infection in a High-Prevalence Country. Cancer Epidemiol. Biomarkers Prev.
16: 662-667
[Abstract][Full Text]
Izzotti, A., De Flora, S., Cartiglia, C., Are, B. M., Longobardi, M., Camoirano, A., Mura, I., Dore, M. P., Scanu, A. M., Rocca, P. C., Maida, A., Piana, A.
(2007). Interplay between Helicobacter pylori and host gene polymorphisms in inducing oxidative DNA damage in the gastric mucosa. Carcinogenesis
28: 892-898
[Abstract][Full Text]
Pflock, M., Bathon, M., Schar, J., Muller, S., Mollenkopf, H., Meyer, T. F., Beier, D.
(2007). The Orphan Response Regulator HP1021 of Helicobacter pylori Regulates Transcription of a Gene Cluster Presumably Involved in Acetone Metabolism. J. Bacteriol.
189: 2339-2349
[Abstract][Full Text]
Orth, J. H. C., Aktories, K., Kubatzky, K. F.
(2007). Modulation of Host Cell Gene Expression through Activation of STAT Transcription Factors by Pasteurella multocida Toxin. J. Biol. Chem.
282: 3050-3057
[Abstract][Full Text]
Larsson, S. C, Bergkvist, L., Naslund, I., Rutegard, J., Wolk, A.
(2007). Vitamin A, retinol, and carotenoids and the risk of gastric cancer: a prospective cohort study. Am. J. Clin. Nutr.
85: 497-503
[Abstract][Full Text]
O'Hara, A. M., Bhattacharyya, A., Mifflin, R. C., Smith, M. F., Ryan, K. A., Scott, K. G.-E., Naganuma, M., Casola, A., Izumi, T., Mitra, S., Ernst, P. B., Crowe, S. E.
(2006). Interleukin-8 Induction by Helicobacter pylori in Gastric Epithelial Cells is Dependent on Apurinic/Apyrimidinic Endonuclease-1/Redox Factor-1. J. Immunol.
177: 7990-7999
[Abstract][Full Text]
Nakajima, T., Maekita, T., Oda, I., Gotoda, T., Yamamoto, S., Umemura, S., Ichinose, M., Sugimura, T., Ushijima, T., Saito, D.
(2006). Higher Methylation Levels in Gastric Mucosae Significantly Correlate with Higher Risk of Gastric Cancers.. Cancer Epidemiol. Biomarkers Prev.
15: 2317-2321
[Abstract][Full Text]
McColl, K E L
(2006). Acid inhibitory medication and risk of gastric and oesophageal cancer.. Gut
55: 1532-1533
[Full Text]
Naylor, G M, Gotoda, T, Dixon, M, Shimoda, T, Gatta, L, Owen, R, Tompkins, D, Axon, A
(2006). Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut
55: 1545-1552
[Abstract][Full Text]
Rodriguez, L A G., Lagergren, J, Lindblad, M
(2006). Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut
55: 1538-1544
[Abstract][Full Text]
Kamangar, F., Dawsey, S. M., Blaser, M. J., Perez-Perez, G. I., Pietinen, P., Newschaffer, C. J., Abnet, C. C., Albanes, D., Virtamo, J., Taylor, P. R.
(2006). Opposing Risks of Gastric Cardia and Noncardia Gastric Adenocarcinomas Associated With Helicobacter pylori Seropositivity.. JNCI J Natl Cancer Inst
98: 1445-1452
[Abstract][Full Text]
Algood, H. M. S., Cover, T. L.
(2006). Helicobacter pylori Persistence: an Overview of Interactions between H. pylori and Host Immune Defenses. Clin. Microbiol. Rev.
19: 597-613
[Abstract][Full Text]
Sugimoto, M., Furuta, T., Shirai, N., Ikuma, M., Sugimura, H., Hishida, A.
(2006). Influences of chymase and Angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan.. Cancer Epidemiol. Biomarkers Prev.
15: 1929-1934
[Abstract][Full Text]
Kuipers, E J
(2006). Proton pump inhibitors and gastric neoplasia.. Gut
55: 1217-1221
[Abstract][Full Text]
Lin, Y.-F., Wu, M.-S., Chang, C.-C., Lin, S.-W., Lin, J.-T., Sun, Y.-J., Chen, D.-S., Chow, L.-P.
(2006). Comparative Immunoproteomics of Identification and Characterization of Virulence Factors from Helicobacter pylori Related to Gastric Cancer. Mol. Cell. Proteomics
5: 1484-1496
[Abstract][Full Text]
Leung, W. K., Ng, E. K.W., Chan, F. K.L., Chan, W. Y., Chan, K.-f., Auyeung, A. C.M., Lam, C. C.H., Lau, J. Y.W., Sung, J. J.Y.
(2006). Effects of Long-term Rofecoxib on Gastric Intestinal Metaplasia: Results of a Randomized Controlled Trial. Clin. Cancer Res.
12: 4766-4772
[Abstract][Full Text]
You, W.-c., Brown, L. M., Zhang, L., Li, J.-y., Jin, M.-l., Chang, Y.-s., Ma, J.-l., Pan, K.-f., Liu, W.-d., Hu, Y., Crystal-Mansour, S., Pee, D., Blot, W. J., Fraumeni, J. F. Jr., Xu, G.-w., Gail, M. H.
(2006). Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.. JNCI J Natl Cancer Inst
98: 974-983
[Abstract][Full Text]
Ruggiero, P., Tombola, F., Rossi, G., Pancotto, L., Lauretti, L., Del Giudice, G., Zoratti, M.
(2006). Polyphenols Reduce Gastritis Induced by Helicobacter pylori Infection or VacA Toxin Administration in Mice.. Antimicrob. Agents Chemother.
50: 2550-2552
[Abstract][Full Text]
Suzuki, T., Matsuo, K., Ito, H., Hirose, K., Wakai, K., Saito, T., Sato, S., Morishima, Y., Nakamura, S., Ueda, R., Tajima, K.
(2006). A past history of gastric ulcers and Helicobacter pylori infection increase the risk of gastric malignant lymphoma. Carcinogenesis
27: 1391-1397
[Abstract][Full Text]
Dean, M.
(2006). CANCER STEM CELLS: Redefining the Paradigm of Cancer Treatment Strategies. Mol. Interv.
6: 140-148
[Abstract][Full Text]
Pflock, M., Finsterer, N., Joseph, B., Mollenkopf, H., Meyer, T. F., Beier, D.
(2006). Characterization of the ArsRS Regulon of Helicobacter pylori, Involved in Acid Adaptation.. J. Bacteriol.
188: 3449-3462
[Abstract][Full Text]
Aoi, T, Marusawa, H, Sato, T, Chiba, T, Maruyama, M
(2006). Risk of subsequent development of gastric cancer in patients with previous gastric epithelial neoplasia.. Gut
55: 588-589
[Full Text]
Oishi, Y., Kiyohara, Y., Kubo, M., Tanaka, K., Tanizaki, Y., Ninomiya, T., Doi, Y., Shikata, K., Yonemoto, K., Shirota, T., Matsumoto, T., Iida, M.
(2006). The Serum Pepsinogen Test as a Predictor of Gastric Cancer: The Hisayama Study. Am J Epidemiol
163: 629-637
[Abstract][Full Text]
Schottenfeld, D., Beebe-Dimmer, J.
(2006). Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.. CA Cancer J Clin
56: 69-83
[Abstract][Full Text]
Maekita, T., Nakazawa, K., Mihara, M., Nakajima, T., Yanaoka, K., Iguchi, M., Arii, K., Kaneda, A., Tsukamoto, T., Tatematsu, M., Tamura, G., Saito, D., Sugimura, T., Ichinose, M., Ushijima, T.
(2006). High Levels of Aberrant DNA Methylation in Helicobacter pylori-Infected Gastric Mucosae and its Possible Association with Gastric Cancer Risk. Clin. Cancer Res.
12: 989-995
[Abstract][Full Text]
Couturier, M. R., Tasca, E., Montecucco, C., Stein, M.
(2006). Interaction with CagF Is Required for Translocation of CagA into the Host via the Helicobacter pylori Type IV Secretion System. Infect. Immun.
74: 273-281
[Abstract][Full Text]
Tsutsumi, R., Takahashi, A., Azuma, T., Higashi, H., Hatakeyama, M.
(2006). Focal Adhesion Kinase Is a Substrate and Downstream Effector of SHP-2 Complexed with Helicobacter pylori CagA. Mol. Cell. Biol.
26: 261-276
[Abstract][Full Text]
Larizza, D., Calcaterra, V., Martinetti, M., Negrini, R., De Silvestri, A., Cisternino, M., Iannone, A. M., Solcia, E.
(2006). Helicobacter pylori Infection and Autoimmune Thyroid Disease in Young Patients: The Disadvantage of Carrying the Human Leukocyte Antigen-DRB1*0301 Allele. J. Clin. Endocrinol. Metab.
91: 176-179
[Abstract][Full Text]
Leung, W. K., Ng, E. K.W., Chan, W. Y., Auyeung, A. C.M., Chan, K.-f., Lam, C. C.H., Chan, F. K.L., Lau, J. Y.W., Sung, J. J.Y.
(2005). Risk Factors Associated with the Development of Intestinal Metaplasia in First-Degree Relatives of Gastric Cancer Patients. Cancer Epidemiol. Biomarkers Prev.
14: 2982-2986
[Abstract][Full Text]
Okuda, M., Sugiyama, T., Fukunaga, K., Kondou, M., Miyashiro, E., Nakazawa, T.
(2005). A Strain-Specific Antigen in Japanese Helicobacter pylori Recognized in Sera of Japanese Children. CVI
12: 1280-1284
[Abstract][Full Text]
Taguchi, A., Ohmiya, N., Shirai, K., Mabuchi, N., Itoh, A., Hirooka, Y., Niwa, Y., Goto, H.
(2005). Interleukin-8 Promoter Polymorphism Increases the Risk of Atrophic Gastritis and Gastric Cancer in Japan. Cancer Epidemiol. Biomarkers Prev.
14: 2487-2493
[Abstract][Full Text]
Stoicov, C., Cai, X., Li, H., Klucevsek, K., Carlson, J., Saffari, R., Houghton, J.
(2005). Major Histocompatibility Complex Class II Inhibits Fas Antigen-Mediated Gastric Mucosal Cell Apoptosis through Actin-Dependent Inhibition of Receptor Aggregation. Infect. Immun.
73: 6311-6321
[Abstract][Full Text]
Pflock, M., Kennard, S., Delany, I., Scarlato, V., Beier, D.
(2005). Acid-Induced Activation of the Urease Promoters Is Mediated Directly by the ArsRS Two-Component System of Helicobacter pylori. Infect. Immun.
73: 6437-6445
[Abstract][Full Text]
Jimenez-Pearson, M.-A., Delany, I., Scarlato, V., Beier, D.
(2005). Phosphate flow in the chemotactic response system of Helicobacter pylori. Microbiology
151: 3299-3311
[Abstract][Full Text]
Marshall, B. J.
(2005). The Lasker Awards: Celebrating Scientific Discovery. JAMA
294: 1420-1421
[Full Text]
Lee, W.-P., Tai, D.-I., Lan, K.-H., Li, A. F.-Y., Hsu, H.-C., Lin, E.-J., Lin, Y.-P., Sheu, M.-L., Li, C.-P., Chang, F.-Y., Chao, Y., Yen, S.-H., Lee, S.-D.
(2005). The -251T Allele of the Interleukin-8 Promoter Is Associated with Increased Risk of Gastric Carcinoma Featuring Diffuse-Type Histopathology in Chinese Population. Clin. Cancer Res.
11: 6431-6441
[Abstract][Full Text]
Yamazaki, S., Yamakawa, A., Okuda, T., Ohtani, M., Suto, H., Ito, Y., Yamazaki, Y., Keida, Y., Higashi, H., Hatakeyama, M., Azuma, T.
(2005). Distinct Diversity of vacA, cagA, and cagE Genes of Helicobacter pylori Associated with Peptic Ulcer in Japan. J. Clin. Microbiol.
43: 3906-3916
[Abstract][Full Text]
Chui, S. Y., Clay, T. M., Lyerly, H. K., Morse, M. A.
(2005). The Development of Therapeutic and Preventive Vaccines for Gastric Cancer and Helicobacter pylori. Cancer Epidemiol. Biomarkers Prev.
14: 1883-1889
[Abstract][Full Text]
Rugge, M, Bersani, G, Bertorelle, R, Pennelli, G, Russo, V M, Farinati, F, Bartolini, D, Cassaro, M, Alvisi, V
(2005). Microsatellite instability and gastric non-invasive neoplasia in a high risk population in Cesena, Italy. J. Clin. Pathol.
58: 805-810
[Abstract][Full Text]
Yokoyama, K., Higashi, H., Ishikawa, S., Fujii, Y., Kondo, S., Kato, H., Azuma, T., Wada, A., Hirayama, T., Aburatani, H., Hatakeyama, M.
(2005). Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epithelial cells. Proc. Natl. Acad. Sci. USA
102: 9661-9666
[Abstract][Full Text]
Higashi, H., Yokoyama, K., Fujii, Y., Ren, S., Yuasa, H., Saadat, I., Murata-Kamiya, N., Azuma, T., Hatakeyama, M.
(2005). EPIYA Motif Is a Membrane-targeting Signal of Helicobacter pylori Virulence Factor CagA in Mammalian Cells. J. Biol. Chem.
280: 23130-23137
[Abstract][Full Text]
McColl, K E L
(2005). Screening for early gastric cancer. Gut
54: 740-742
[Full Text]
Watabe, H, Mitsushima, T, Yamaji, Y, Okamoto, M, Wada, R, Kokubo, T, Doi, H, Yoshida, H, Kawabe, T, Omata, M
(2005). Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut
54: 764-768
[Abstract][Full Text]
Konno, M., Fujii, N., Yokota, S.-i., Sato, K., Takahashi, M., Sato, K., Mino, E., Sugiyama, T.
(2005). Five-Year Follow-Up Study of Mother-to-Child Transmission of Helicobacter pylori Infection Detected by a Random Amplified Polymorphic DNA Fingerprinting Method. J. Clin. Microbiol.
43: 2246-2250
[Abstract][Full Text]
Kato, S., Sherman, P. M.
(2005). What Is New Related to Helicobacter pylori Infection in Children and Teenagers?. Arch Pediatr Adolesc Med
159: 415-421
[Abstract][Full Text]
Wei, D., Gong, W., Kanai, M., Schlunk, C., Wang, L., Yao, J. C., Wu, T.-T., Huang, S., Xie, K.
(2005). Drastic Down-regulation of Kruppel-Like Factor 4 Expression Is Critical in Human Gastric Cancer Development and Progression. Cancer Res.
65: 2746-2754
[Abstract][Full Text]
Yamagata, H., Kiyohara, Y., Nakamura, S., Kubo, M., Tanizaki, Y., Matsumoto, T., Tanaka, K., Kato, I., Shirota, T., Iida, M.
(2005). Impact of Fasting Plasma Glucose Levels on Gastric Cancer Incidence in a General Japanese Population: The Hisayama Study. Diabetes Care
28: 789-794
[Abstract][Full Text]
Peek, R. M. Jr.
(2005). Orchestration of Aberrant Epithelial Signaling by Helicobacter pylori CagA. Sci Signal
2005: pe14-pe14
[Abstract][Full Text]
Ohyauchi, M, Imatani, A, Yonechi, M, Asano, N, Miura, A, Iijima, K, Koike, T, Sekine, H, Ohara, S, Shimosegawa, T
(2005). The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut
54: 330-335
[Abstract][Full Text]
Tanaka, J., Fukuda, Y., Shintani, S., Hori, K., Tomita, T., Ohkusa, T., Matsumoto, T., Miwa, H.
(2005). Influence of antimicrobial treatment for Helicobacter pylori infection on the intestinal microflora in Japanese macaques. J Med Microbiol
54: 309-314
[Abstract][Full Text]
Terry, K., Williams, S. M., Connolly, L., Ottemann, K. M.
(2005). Chemotaxis Plays Multiple Roles during Helicobacter pylori Animal Infection. Infect. Immun.
73: 803-811
[Abstract][Full Text]
Osawa, H., Nakazato, M., Date, Y., Kita, H., Ohnishi, H., Ueno, H., Shiiya, T., Satoh, K., Ishino, Y., Sugano, K.
(2005). Impaired Production of Gastric Ghrelin in Chronic Gastritis Associated with Helicobacter pylori. J. Clin. Endocrinol. Metab.
90: 10-16
[Abstract][Full Text]
Glas, J., Torok, H.-P., Schneider, A., Brunnler, G., Kopp, R., Albert, E. D., Stolte, M., Folwaczny, C.
(2004). Allele 2 of the Interleukin-1 Receptor Antagonist Gene Is Associated With Early Gastric Cancer. JCO
22: 4746-4752
[Abstract][Full Text]
Cui, G., Koh, T. J., Chen, D., Zhao, C.-M., Takaishi, S., Dockray, G. J., Varro, A., Rogers, A. B., Fox, J. G., Wang, T. C.
(2004). Overexpression of Glycine-Extended Gastrin Inhibits Parietal Cell Loss and Atrophy in the Mouse Stomach. Cancer Res.
64: 8160-8166
[Abstract][Full Text]
Mutoh, H., Sakurai, S., Satoh, K., Tamada, K., Kita, H., Osawa, H., Tomiyama, T., Sato, Y., Yamamoto, H., Isoda, N., Yoshida, T., Ido, K., Sugano, K.
(2004). Development of Gastric Carcinoma from Intestinal Metaplasia in Cdx2-transgenic Mice. Cancer Res.
64: 7740-7747
[Abstract][Full Text]
Bergman, M. P., Engering, A., Smits, H. H., van Vliet, S. J., van Bodegraven, A. A., Wirth, H.-P., Kapsenberg, M. L., Vandenbroucke-Grauls, C. M.J.E., van Kooyk, Y., Appelmelk, B. J.
(2004). Helicobacter pylori Modulates the T Helper Cell 1/T Helper Cell 2 Balance through Phase-variable Interaction between Lipopolysaccharide and DC-SIGN. J. Exp. Med.
200: 979-990
[Abstract][Full Text]
Minami, M., Ando, T., Hashikawa, S.-n., Torii, K., Hasegawa, T., Israel, D. A., Ina, K., Kusugami, K., Goto, H., Ohta, M.
(2004). Effect of Glycine on Helicobacter pylori In Vitro. Antimicrob. Agents Chemother.
48: 3782-3788
[Abstract][Full Text]
Huff, J. L., Hansen, L. M., Solnick, J. V.
(2004). Gastric Transcription Profile of Helicobacter pylori Infection in the Rhesus Macaque. Infect. Immun.
72: 5216-5226
[Abstract][Full Text]
Correa, P
(2004). Is gastric cancer preventable?. Gut
53: 1217-1219
[Abstract][Full Text]
Leung, W K, Lin, S-R, Ching, J Y L, To, K-F, Ng, E K W, Chan, F K L, Lau, J Y W, Sung, J J Y
(2004). Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut
53: 1244-1249
[Abstract][Full Text]
Derakhshan, M H, Yazdanbod, A, Sadjadi, A R, Shokoohi, B, McColl, K E L, Malekzadeh, R
(2004). High incidence of adenocarcinoma arising from the right side of the gastric cardia in NW Iran. Gut
53: 1262-1266
[Abstract][Full Text]
Lee, K.-H., Cho, M.-J., Yamaoka, Y., Graham, D. Y., Yun, Y.-J., Woo, S.-Y., Lim, C.-Y., Ko, K.-S., Kim, B.-J., Jung, H.-C., Lee, W.-K., Rhee, K.-H., Kook, Y.-H.
(2004). Alanine-Threonine Polymorphism of Helicobacter pylori RpoB Is Correlated with Differential Induction of Interleukin-8 in MKN45 Cells. J. Clin. Microbiol.
42: 3518-3524
[Abstract][Full Text]
Liu, Y., Kaneko, S., Sobue, T.
(2004). Trends in reported incidences of gastric cancer by tumour location, from 1975 to 1989 in Japan. Int J Epidemiol
33: 808-815
[Abstract][Full Text]
Ishihara, S., Rumi, M. A. K., Kadowaki, Y., Ortega-Cava, C. F., Yuki, T., Yoshino, N., Miyaoka, Y., Kazumori, H., Ishimura, N., Amano, Y., Kinoshita, Y.
(2004). Essential Role of MD-2 in TLR4-Dependent Signaling during Helicobacter pylori-Associated Gastritis. J. Immunol.
173: 1406-1416
[Abstract][Full Text]
Lehours, P, Dupouy, S, Bergey, B, Ruskone-Foumestraux, A, Delchier, J C, Rad, R, Richy, F, Tankovic, J, Zerbib, F, Megraud, F, Menard, A
(2004). Identification of a genetic marker of Helicobacter pylori strains involved in gastric extranodal marginal zone B cell lymphoma of the MALT-type. Gut
53: 931-937
[Abstract][Full Text]
Rossi, G., Ruggiero, P., Peppoloni, S., Pancotto, L., Fortuna, D., Lauretti, L., Volpini, G., Mancianti, S., Corazza, M., Taccini, E., Di Pisa, F., Rappuoli, R., Del Giudice, G.
(2004). Therapeutic Vaccination against Helicobacter pylori in the Beagle Dog Experimental Model: Safety, Immunogenicity, and Efficacy. Infect. Immun.
72: 3252-3259
[Abstract][Full Text]
Eguchi, H, Carpentier, S, Kim, S S, Moss, S F
(2004). p27kip1 regulates the apoptotic response of gastric epithelial cells to Helicobacter pylori. Gut
53: 797-804
[Abstract][Full Text]
Higashi, H., Nakaya, A., Tsutsumi, R., Yokoyama, K., Fujii, Y., Ishikawa, S., Higuchi, M., Takahashi, A., Kurashima, Y., Teishikata, Y., Tanaka, S., Azuma, T., Hatakeyama, M.
(2004). Helicobacter pylori CagA Induces Ras-independent Morphogenetic Response through SHP-2 Recruitment and Activation. J. Biol. Chem.
279: 17205-17216
[Abstract][Full Text]
Merkx-Jacques, A., Obhi, R. K., Bethune, G., Creuzenet, C.
(2004). The Helicobacter pylori flaA1 and wbpB Genes Control Lipopolysaccharide and Flagellum Synthesis and Function. J. Bacteriol.
186: 2253-2265
[Abstract][Full Text]